Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025

Bulletin Express12-01

Shandong Xinhua Pharmaceutical Company Limited, stock codes 00719 (H shares) and 000756 (A shares), released its monthly return announcement for the period ended 30 November 2025. According to the filing, the authorized share capital remained at RMB 689,776,535, comprising 195,000,000 H shares of RMB 1.00 par value and 494,776,535 A shares of RMB 1.00 par value, with no changes noted during the month.

The number of issued shares also remained unchanged, totaling 195,000,000 H shares and 494,776,535 A shares. Under the 2021 Share Option Scheme for A shares, 9,118,900 options remained outstanding, with no new shares issued and no treasury shares transferred. No funds were raised from option exercises, and no treasury shares were held or cancelled. The company confirmed that all regulatory requirements and listing rules continue to be duly met, with no additional share issuances or changes in share capital over the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103805888?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 08:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103805888","market":"us","top_or_hot":-1,"title":"Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025","media":"Bulletin Express","content":"<p>Shandong Xinhua Pharmaceutical Company Limited, stock codes 00719 (H shares) and 000756 (A shares), released its monthly return announcement for the period ended 30 November 2025. According to the filing, the authorized share capital remained at RMB 689,776,535, comprising 195,000,000 H shares of RMB 1.00 par value and 494,776,535 A shares of RMB 1.00 par value, with no changes noted during the month.</p>\n<p>The number of issued shares also remained unchanged, totaling 195,000,000 H shares and 494,776,535 A shares. Under the 2021 Share Option Scheme for A shares, 9,118,900 options remained outstanding, with no new shares issued and no treasury shares transferred. No funds were raised from option exercises, and no treasury shares were held or cancelled. The company confirmed that all regulatory requirements and listing rules continue to be duly met, with no additional share issuances or changes in share capital over the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 08:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Xinhua Pharmaceutical Company Limited, stock codes 00719 (H shares) and 000756 (A shares), released its monthly return announcement for the period ended 30 November 2025. According to the filing, the authorized share capital remained at RMB 689,776,535, comprising 195,000,000 H shares of RMB 1.00 par value and 494,776,535 A shares of RMB 1.00 par value, with no changes noted during the month.</p>\n<p>The number of issued shares also remained unchanged, totaling 195,000,000 H shares and 494,776,535 A shares. Under the 2021 Share Option Scheme for A shares, 9,118,900 options remained outstanding, with no new shares issued and no treasury shares transferred. No funds were raised from option exercises, and no treasury shares were held or cancelled. The company confirmed that all regulatory requirements and listing rules continue to be duly met, with no additional share issuances or changes in share capital over the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00719","symbol_name":"山东新华制药股份","start_time":0,"source_url":"","article_id":"1103805888","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103805888","pubTimestamp":1764548487,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Xinhua Pharmaceutical Company Limited, stock codes 00719 (H shares) and 000756 (A shares), released its monthly return announcement for the period ended 30 November 2025. According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00719":"山东新华制药股份"},"translate_title":"山东新华制药(00719)公布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":1},"content_text":"Shandong Xinhua Pharmaceutical Company Limited, stock codes 00719 (H shares) and 000756 (A shares), released its monthly return announcement for the period ended 30 November 2025. According to the filing, the authorized share capital remained at RMB 689,776,535, comprising 195,000,000 H shares of RMB 1.00 par value and 494,776,535 A shares of RMB 1.00 par value, with no changes noted during the month.\nThe number of issued shares also remained unchanged, totaling 195,000,000 H shares and 494,776,535 A shares. Under the 2021 Share Option Scheme for A shares, 9,118,900 options remained outstanding, with no new shares issued and no treasury shares transferred. No funds were raised from option exercises, and no treasury shares were held or cancelled. The company confirmed that all regulatory requirements and listing rules continue to be duly met, with no additional share issuances or changes in share capital over the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103805888","isCrawlerRequest":true}